Status
Conditions
Treatments
About
The goal of the Vida Sana y Completa study is to provide evidence on the most effective approach for addressing the critical combination of obesity and food insecurity among Latinas in primary care while also collecting preliminary information on the potential for implementation and dissemination.
Full description
The goal of this study is to compare two approaches to addressing obesity and food insecurity among Latina women in primary care to provide evidence for community health centers who serve this high-priority group. The project team will recruit 412 low-income Latina women with obesity (body mass index 30) and food insecurity from two community health centers with whom the team has longstanding partnerships. Patients will be randomized to Vida Sana y Completa (an obesity intervention with integrated treatment for food insecurity) or Vida Sana alone. Vida Sana is a state-of-the-art cultural adaptation of Group Lifestyle Balance, a 12-month program that targets at least 5 percent weight loss and at least 150 minutes per week of moderate-to-vigorous physical activity. For food insecurity, the team will provide boxes of healthy foods (e.g., fresh produce, lean protein, low-fat dairy, and whole grains) that give women the foods they need to adopt a healthy diet.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Previous diagnosis of diabetes (other than during pregnancy) or diabetes documented in the EHR
Diagnosis of cancer (other than non-melanoma skin cancer) that is/was active or treated with radiation or chemotherapy within the past 2 years
Serious medical condition anticipated to prevent person from walking
1 mile (e.g., severe pulmonary disease or aortic stenosis)
Severe medical comorbidities that require aggressive treatment: e.g., stage 4 or greater renal disease, class III or greater heart failure, unstable coronary artery disease, liver or renal failure;
Diagnosis of a terminal illness and/or in hospice care;
Diagnosis of bipolar disorder or psychotic disorder within the last 2 years, or currently taking a mood stabilizer or antipsychotic medication
Initiation or change in type or dosing of antidepressant medications within 2 months prior to enrollment (The patient will be re-contacted for a later cohort once his/her regimen has been stable for at least 2 months unless the person declines to participate altogether.)
Have had or plan to undergo bariatric surgery during the study period
Other exclusions:
Primary purpose
Allocation
Interventional model
Masking
412 participants in 2 patient groups
Loading...
Central trial contact
Michelle Ordonez Arango
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal